Literature DB >> 19553040

Laryngeal kaposiform hemangioendothelioma: case report and literature review.

Dong Wook Kim1, Jin Haeng Chung, Soon Hyun Ahn, Tack-Kyun Kwon.   

Abstract

The kaposiform hemangioendothelioma (KHE) is an uncommon vascular neoplasm of borderline or intermediate malignant potential in which involvement of the head and neck region is rare. A 5-year-old girl was admitted to the emergency room with abrupt massive hemoptysis. Transoral laryngoscopy revealed a round, reddish mass with active bleeding on the anterior portion of the left vocal fold region. Since re-hemoptysis and large amount of aspiration caused breathing difficulties for the patient, suspension exam was performed under general anesthesia. Mass excision and thorough bleeding control was performed with laser assisted laryngo-micro system. Postoperatively, there was no further bleeding. The pathologic diagnosis of the tumor was KHE. To the best of our knowledge, this is the first report of a KHE in the larynx presenting as recurrent hemoptysis in childhood. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19553040     DOI: 10.1016/j.anl.2009.05.003

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  3 in total

1.  Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.

Authors:  Stacy E Croteau; Marilyn G Liang; Harry P Kozakewich; Ahmad I Alomari; Steven J Fishman; John B Mulliken; Cameron C Trenor
Journal:  J Pediatr       Date:  2012-08-04       Impact factor: 4.406

2.  Case Report: Congenital Intracranial Kaposiform Hemangioendothelioma Treated With Surgical Resection.

Authors:  Yingjie Cai; Jiayi Li; Wei Yang; Nan Zhang; Hailang Sun; Weiping Zhang; Ming Ge
Journal:  Front Surg       Date:  2022-04-01

Review 3.  Kaposiform hemangioendothelioma: current knowledge and future perspectives.

Authors:  Yi Ji; Siyuan Chen; Kaiying Yang; Chunchao Xia; Li Li
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.